首页>Influenza and other respiratory viruses>An assessment of prime-boost vaccination schedules with AS03A-adjuvanted prepandemic H5N1 vaccines: A randomized study in European adults
An assessment of prime-boost vaccination schedules with AS03A-adjuvanted prepandemic H5N1 vaccines: A randomized study in European adults
作者单位:GlaxoSmithKline Biologicals, Wavre, Belgium[1]GlaxoSmithKline Biologicals, King of Prussia, PA, United States[2]Department of Pediatrics, Johannes Gutenberg-University Mainz, Children's Hospital, Wiesbaden[3]Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Würzburg, Germany[4]